Biovail Corporation volatility and risk adjusted return

These are some of this Monday's top analyst upgrades and downgrades seen from Wall Street research calls: Anadarko Petroleum Corporation (NYSE: APC) Cut to Market Perform at FBR. Biovail Inc. (NYSE: BVF) Cut to Hold at TD.

Maybe smaller Gorilla head larger BVF -or- whatever that graphic is on the sidepanel should be on the front with the stars explored a bit more. The bib front - Looks good. Bib back - design cop out - missed opportunity. ...

BVF President Richard Callicott said: ?Since 2009, the BVF has faced increasing difficulties in continuing to support all of its programmes within the funding allocation made available to it by UK Sport. ...

[Zacks] - The FDA has extended the review date for Glaxo and Valeant's epilepsy candidate, ezogabine, by three months.

Zacks Analyst Blog Highlights: Biovail, Valeant Pharma, DeVry, Advance Auto Parts and Halliburton Company

[Zacks] - Biovail Corporation's second quarter earnings of 34 cents per share comfortably surpassed the Zacks Consensus Estimate of 26 cents per share.